ClinicalTrials.Veeva

Menu

Oocyte Vitrification Aided With Cytochalasin B

I

Ibn Sina Hospital

Status

Completed

Conditions

Infertility

Treatments

Other: Cytochalasin B supplemented vitrification medium

Study type

Interventional

Funder types

Other

Identifiers

NCT03678558
IbnSina-Oocyte-CB

Details and patient eligibility

About

Using the cytoskeleton Stabilizer the Cytochalasin B would improve the outcome of oocyte vitrification.

Enrollment

612 patients

Sex

Female

Ages

18 to 42 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • indication for oocyte vitrification

Exclusion criteria

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

612 participants in 2 patient groups

Cytochalasin B supplemented vitrification medium
Experimental group
Treatment:
Other: Cytochalasin B supplemented vitrification medium
Vitrification medium with no supplementation
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems